MedTrace Logo

Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus

NCT00002884 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 326

Last updated 2013-08-07

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known whether external-beam radiation therapy plus chemotherapy is more effective with or without internal radiation therapy.

PURPOSE: Randomized phase III trial to compare chemotherapy and external-beam radiation therapy with or without internal radiation therapy in treating patients with stage I, stage II, or stage III esophageal cancer.

Conditions

  • Esophageal Cancer

Interventions

DRUG

chemotherapy

DRUG

cisplatin

DRUG

fluorouracil

RADIATION

brachytherapy

RADIATION

radiation therapy

Sponsors & Collaborators

  • Centre Hospitalier Lyon Sud

    lead OTHER

Principal Investigators

  • Jean-Pierre Gerard, MD · Centre Hospitalier Lyon Sud

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
18 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002884 on ClinicalTrials.gov